IP Library Granted Patent US 10,246,430
Granted Patent B2
US 10,246,430 · App. 15/971,132 · Granted Apr 2, 2019

Methods for producing Beraprost and its derivatives

Inventors: Hitesh Batra (Herndon, VA); Sudersan M. Tuladhar (Silver Spring, MD); Sri Harsha Tummala (Owings Mills, MD); Raju Penmasta (Herndon, VA); David A. Walsh (Spotsylvania, VA)
Assignee: Lung Biotechnology PBC
C07D307/93C07C67/00C07C67/307C07C69/65C07C233/20C07C2101/10C07C2601/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,246,430
App. No.
15/971,132
Granted
Apr 2, 2019
Kind
B2
Abstract

The present invention is directed to methods for preparing Beraprost and novel synthetic intermediates for Beraprost.

Claims (26)

1. A method of preparing a compound represented by the structural Formula (I):

and salts thereof; comprising:

(a) reacting a substituted halophenol with 6-oxabicyclo[3.1.0]hex-2-ene in presence of a palladium catalyst to form an ether compound represented by structural Formula (III):

(b) acetylating the ether compound of Formula (III) to form a compound of Formula (IV)

(c) allylating the compound of Formula (IV) with allyltributylstannane in presence of AIBN to form the allylation product (V)

(d) subjecting the terminal alkene compound of Formula (V) to intermolecular allylic acetoxylation to form a compound of Formula (VI)

(e) subjecting the compound of Formula (VI) to dihydroxylation to form a compound of Formula (VII)

(f) subjecting the dihydroxy compound (VII) to oxidation to form an aldehyde compound of Formula (VIII)

(g) reducing the aldehyde compound of Formula (VIII) and removing the acetyl group to provide the diol compound of Formula (IX); and

(h) converting the diol of Formula (IX) to a protected aldehyde of Formula (VIIIA); and

(i) reacting the protected aldehyde of Formula (VIIIA) with a phosphonate of Formula (X) to obtain a compound of Formula (I)

wherein:

X is F, Cl, Br or I;

R 1 is an alkyl, cycloalkyl or TBDMS;

R 2 is independently H or an alcohol protecting group;

R 3 is a straight or branched alkyl group having 1-4 carbon atoms; and

R 6 is an alcohol protecting group.

2. The method of claim 1 , wherein R 1 is methyl or ethyl.

3. The method of claim 1 , wherein the palladium catalyst is PdCl 2 (PPh 3 ) 2 .

4. The method of claim 1 , wherein the allylation reaction is carried out in the presence of an allylating reagent.

5. The method of claim 1 , wherein the allylic acetoxylation reaction is carried out in the presence of acetic acid and PdCl 2 catalyst.

6. The method of claim 1 , wherein the catalytic dihydroxylation is carried out in the presence of N-methylmorpholine N-oxide (NMO) oxidant and a catalytic amount of OsO 4 .

7. The method of claim 1 , wherein the dihydroxy compound (VII) is oxidized in the presence of a periodate compound.

8. The method of claim 1 , wherein the transition metal catalyst is a hydride of ruthenium, iridium, cobalt, rhodium, osmium, platinum, nickel, iron, or combinations thereof or a carbonyl hydride complex of ruthenium, iridium, cobalt, rhodium, osmium, platinum, nickel, iron, or combinations thereof.

9. The method of claim 1 , wherein the transition metal catalyst is a ruthenium hydride complex.

10. The method of claim 1 , wherein the transition metal catalyst carbonylchlorohydridotris(triphenylphosphine)ruthenium(II).

Continuity (4)
Division 15312295
Provisional Application 62000800 · May 20, 2014
Provisional Application 62006360 · Jun 2, 2014
Related Publication 20180265490A1 · Sep 20, 2018